BICO.ST
Get informed when a big investor buys or sells
+ Follow| Market cap | $1.64 Billion |
|---|---|
| Enterprise Value | $1.28 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-15.43 |
| Beta | 2.56 |
| Outstanding Shares | 70,574,895 |
| P/E Ratio | -1.99 |
|---|---|
| PEG | 2.5 |
| Price to Sales | 1.14 |
| Price to Book Ratio | 1.09 |
| Enterprise Value to Revenue | 0.85 |
| Enterprise Value to EBIT | -1.03 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.17 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
BICO Group AB (publ), originally founded in 2016 as Cellink AB (publ) in Gothenburg, Sweden, and subsequently renamed in August 2021, functions as a bio-convergence leader. The company extends its operations internationally, with a prese...